[{"Assets_0_Q2_USD":444721000.0,"CommonStockSharesOutstanding_0_Q2_shares":39080152.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-58597000.0,"NetIncomeLoss_2_Q2_USD":-61389000.0,"NetIncomeLoss_1_Q2_USD":-33412000.0,"StockholdersEquity_0_Q2_USD":374089000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":35997572.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":38774591.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":35997572.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":38774591.0,"Ticker":"BPMC","CIK":"1597264","name":"BLUEPRINT MEDICINES CORP","OfficialName":"Blueprint Medicines Corporation Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"3980842399.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170802"}]